D-Ribose-1,2-¹³C₂

Cat. No.: HY-W018772S16: FAQs
Data Sheet Handling Instructions

Molarity Calculator

D-Ribose-1,2-¹³C₂ is the ¹³C labled D-Ribose(mixture of isomers) (HY-W018772). D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner.

For research use only. We do not sell to patients.

D-Ribose-1,2-<sup>13</sup>C<sub>2</sub> Chemical Structure

D-Ribose-1,2-¹³C₂ Chemical Structure

CAS No. : 209909-88-6

Size		Stock
1 mg		Get quote	Estimated Time of Arrival: December 31

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of D-Ribose-1,2-¹³C₂:

D-Ribose(mixture of isomers) In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	D-Ribose-1,2-¹³C₂ is the ¹³C labled D-Ribose(mixture of isomers) (HY-W018772)^[1]. D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner^[2].
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. D-Ribose-1,2-¹³C₂ Related Antibodies
Molecular Weight	152.12
Formula	C₃¹³C₂H₁₀O₅
CAS No.	209909-88-6
SMILES	OC[C@@H](O)[C@@H](O)[13C@@H](O)[13CH]=O
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Data Sheet (269 KB) Handling Instructions (2659 KB)
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]